The fact
The initial study did not mention this fatality, which occurred during an experimental protocol.
This case reignites the debate on the safety and ethics of gene therapies in China.
Click the link to read an article on the topic:
Why it matters
Ce décès soulève des questions cruciales sur la régulation des essais cliniques en Chine et les risques des thérapies géniques, un domaine en pleine expansion mais encore mal maîtrisé.